Clinical trials
beta-Thalassemia trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
37 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2019 | 4 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 9 |
| 2024 | 9 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 11 |
| Recruiting | 9 |
| Completed | 6 |
| Active, not recruiting | 5 |
| Enrolling by invitation | 3 |
| Not yet recruiting | 1 |
| Suspended | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| CorrectSequence Therapeutics Co., Ltd | 5 |
| Institute of Hematology & Blood Diseases Hospital, China | 5 |
| Nanfang Hospital, Southern Medical University | 5 |
| Bioray Laboratories | 4 |
| First Affiliated Hospital of Guangxi Medical University | 4 |
| Celgene | 2 |
| Children's Hospital of Fudan University | 2 |
| Bristol-Myers Squibb | 1 |
| EdiGene (GuangZhou) Inc. | 1 |
| Guangzhou Women and Children's Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| beta-Thalassemia | 37 |
| Thalassemia | 2 |
| Graft vs Host Disease | 1 |
| Myelodysplastic Syndromes | 1 |
| Myeloproliferative Disorders | 1 |
| Puberty, Delayed | 1 |
Trials
Showing 26 to 37 of 37. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.